Study researchers evaluated the efficacy of ST-Lysyal, an ocular surface modulator, compared with hyaluronic acid eye drops in patients with dry eye disease. The results demonstrated significant improvements in symptom severity, tear film breakup time, and corneal staining for those receiving T-Lys eye drops. The investigators also discussed T-Lys's potential mechanism of action. They suggested the need for larger studies to confirm the obtained results and investigate the efficacy of T-Lys in other ocular surface diseases.

Source: Ophthalmology and Therapy